| 1 |
33636353 | Antihypertensive drug valsartan as a novel BDK inhibitor. | 2021 May |
2 |
| 2 |
33707301 | Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension. | 2021 Jun |
2 |
| 3 |
34697992 | Valsartan alleviates the blood-brain barrier dysfunction in db/db diabetic mice. | 2021 Dec |
1 |
| 4 |
29674000 | Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells. | 2018 Aug |
1 |
| 5 |
26672616 | Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney. | 2016 Mar 1 |
2 |
| 6 |
27102209 | Valsartan inhibits amylin-induced podocyte damage. | 2016 Jul |
1 |
| 7 |
25485905 | Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling. | 2015 Feb 15 |
1 |
| 8 |
24662196 | Angiotensin II type 1 receptor blockade suppresses light-induced neural damage in the mouse retina. | 2014 Jun |
1 |
| 9 |
22805546 | Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway. | 2013 Sep 10 |
1 |
| 10 |
21987107 | Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice. | 2011 Dec |
1 |
| 11 |
20100990 | Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. | 2010 Mar |
3 |
| 12 |
20136508 | Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. | 2010 Sep 15 |
2 |
| 13 |
18327089 | The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. | 2008 Apr |
2 |
| 14 |
18787107 | Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. | 2008 Dec |
2 |